Specialists at Mayo Clinic have used off-label rituximab to treat nearly 30 patients with fibrosing mediastinitis successfully. Disease progression was almost universally halted and two-thirds of the patients improved symptomatically.
Teng Moua, M.D., discusses recent clinical trials and current research into the treatment of idiopathic pulmonary fibrosis (IPF) and non-IPF-progressive interstitial lung diseases.
Mayo Clinic's Center for Sleep Medicine team provides multidisciplinary care for children in special populations, or those with medically complex needs.
Mayo Clinic's home-based pulmonary rehabilitation program provides patients who have chronic obstructive pulmonary disease (COPD) with a health coach and a computer-guided activity and monitoring program.
Mayo Clinic has joined five other medical centers to conduct a multicenter trial, enrolling 300 patients to prospectively evaluate the use of a robotic bronchoscopy system.
Topics include clinical advances in pulmonary, critical care and sleep medicine; evaluation and management of various respiratory diseases; preventive and therapeutic techniques for optimal patient experiences; and medical practice guidelines.
